Indivior Pharmaceuticals, Inc. - Common Stock (INDV)
33.89
-0.55 (-1.60%)
NASDAQ · Last Trade: Feb 22nd, 5:27 PM EST

Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Via The Motley Fool · February 22, 2026

Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Via The Motley Fool · February 22, 2026

Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Via The Motley Fool · February 22, 2026
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Casechartmill.com
Via Chartmill · February 20, 2026
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setupchartmill.com
Via Chartmill · January 27, 2026

Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
Via The Motley Fool · February 22, 2026
The new holding places Flywire outside the fund’s top five positions.
Via The Motley Fool · December 30, 2025
INDIVIOR stock combines high-growth earnings momentum with a strong technical uptrend and a current bull flag setup for a potential breakout.
Via Chartmill · December 29, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via The Motley Fool · December 28, 2025
The position previously accounted for 7.48% of fund AUM as of the prior quarter.
Via The Motley Fool · December 18, 2025
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via The Motley Fool · December 7, 2025
One fund just made a bold bet on a telecom stock undergoing a big transformation
Via The Motley Fool · December 7, 2025
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Via The Motley Fool · December 7, 2025
A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.
Via The Motley Fool · December 7, 2025
Divisadero’s $95 million selloff sends a message about where Remitly stands in the shifting economics of global money movement. Here’s what that signal may mean for long-term investors.
Via The Motley Fool · December 3, 2025
This company is accelerating sales growth in its key prescription medication.
Via The Motley Fool · October 30, 2025
INDIVIOR (INDV) shows strong technicals with a perfect 10 rating and a 9 setup score, signaling a potential breakout above $25.20 resistance.
Via Chartmill · October 20, 2025
Via Benzinga · August 6, 2025